BSN medical Investment Pays Off For EQT In €2.7bn Deal
BSN medical is changing owners for the third time in a decade, with a multi-billion-euro deal that will see the wound-care and orthopedics specialist enter the folds of SCA, a Swedish group that sells consumer health-care products, among other things.
You may also be interested in...
Medtech companies raised $2.4 billion in the fourth quarter, the second-strongest of the year; Q4 device M&A deals totaled $9 billion in value, led by Allergan's $2.9 billion buy of Acelity's LifeCell division. Diagnostics financings finished out the year at $721 million, an increase over the previous quarter and 2016's second-highest quarter, but diagnostics M&A activity was the lowest of the year at $87 million, with only two completed acquisitions.
BSN medical has completed a hat trick of acquisitions with its third lymphedema therapy-related purchase this year. The addition of Oakdale, Pennsylvania-based Wright Therapy Products, Inc. will further expand the US presence of BSN, which is headquartered in Hamburg, Germany, as well as add a new technology platform to its vascular care offering.
Confirming several weeks of speculation, German wound care specialist BSN Medical has a new owner – Swedish private equity firm EQT Partners. The deal has an enterprise value of €1.8bn ($2.25bn).